Announcements Trials

Browse Landscape

Phase

Phase 1 2 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Cisplatin 130 Radiotherapy 94 Carboplatin 84 Fluorouracil 78 Paclitaxel 77 Cyclophosphamide 77 Gemcitabine 72 Capecitabine 66 Docetaxel 64 Doxorubicin 60 Oxaliplatin 58 Etoposide 57 Leucovorin 49 Vincristine 47 Chemotherapy, Adjuvant 42 Cytarabine 38 Dexamethasone 35 Drug Therapy 33 Bevacizumab 31 Epirubicin 29 Pemetrexed 27 Neoadjuvant Therapy 26 Irinotecan 25 Tamoxifen 24 Prednisone 24 Methotrexate 21 Rituximab 20 Vinorelbine 18 Radiotherapy, Intensity-Modulated 18 Peripheral Blood Stem Cell Transplantation 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Unknown × SKLB1028 × Clear all

NCT04716114 2021-11-02

ALIVE

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡